HIV Protease Inhibitors
Showing 1 - 25 of >10,000
HIV, Cardiovascular Diseases, Hypertension Trial in United States (Indinavir sulfate, Ritonavir, Amlodipine)
Completed
- HIV Infections
- +2 more
- Indinavir sulfate
- +3 more
-
San Francisco, California
- +8 more
Oct 28, 2021
HIV-1 Infection Trial (Doravirine, Tenofovir, Lamivudine, Baseline regimen of ritonavir- or cobicistat-boosted protease
Active, not recruiting
- HIV-1 Infection
- Doravirine, Tenofovir, Lamivudine
- +4 more
- (no location specified)
Sep 2, 2022
HIV-1-infection, Multi-Antiviral Resistance Trial in Milan (REGISTER CREATION)
Recruiting
- HIV-1-infection
- Multi-Antiviral Resistance
- REGISTER CREATION
-
Milan, MI, ItalyOspedale San Raffaele
Dec 22, 2021
HIV Trial in United States (Pravastatin sodium, Simvastatin, Atorvastatin calcium)
Completed
- HIV Infections
- Pravastatin sodium
- +5 more
-
Los Angeles, California
- +12 more
Oct 27, 2021
HIV Patients Trial in France (No intervention)
Completed
- HIV Patients
- No intervention
-
Créteil, France
- +5 more
Jul 30, 2021
HIV I Infection, Adiposity Trial in Saint Louis (Frequently sampled glucose tolerance testing, abdominal subcutaneous adipose
Recruiting
- HIV I Infection
- Adiposity
- Frequently sampled glucose tolerance testing
- +2 more
-
Saint Louis, MissouriWashington University School of Medicine
Jun 15, 2022
Protease Inhibitors in Chronic Hepatitis C
Completed
- Chronic Hepatitis C
-
Graz, AustriaDepartment of Internal Medicine, Medical University of Graz
Jan 11, 2023
HIV Trial in Puerto Rico, United States (Indinavir sulfate, Abacavir sulfate, Amprenavir)
Completed
- HIV Infections
- Indinavir sulfate
- +7 more
-
Los Angeles, California
- +44 more
Oct 27, 2021
HIV Trial in Bangkok (generic single tablet TAF/FTC/DTG)
Active, not recruiting
- HIV
- generic single tablet TAF/FTC/DTG
-
Bangkok, Thailand
- +1 more
Mar 22, 2022
HIV Trial in United States (Indinavir sulfate, Ritonavir, Nelfinavir mesylate)
Completed
- HIV Infections
- Indinavir sulfate
- +3 more
-
San Francisco, California
- +14 more
Oct 27, 2021
HIV-1-infection Trial in Worldwide (Dolutegravir & Rilpivirine 2 drug fixed dose combined therapy)
Active, not recruiting
- HIV-1-infection
- Dolutegravir & Rilpivirine 2 drug fixed dose combined therapy
-
Antwerp, Belgium
- +28 more
May 23, 2022
HIV Trial in United States (Indinavir sulfate, Ritonavir, Amprenavir)
Completed
- HIV Infections
- Indinavir sulfate
- +5 more
-
Palo Alto, California
- +7 more
Oct 28, 2021
Tuberculous Meningitis, HIV I Infection Trial in Rio De Janeiro, Maputo, Lusaka (Adalimumab Injection)
Not yet recruiting
- Tuberculous Meningitis
- HIV I Infection
- Adalimumab Injection
-
Rio De Janeiro, Brazil
- +2 more
Jan 31, 2023
HIV I Infection, Cardiovascular Risk Factor, Lipid Metabolism Disorders Trial (Doravirine 100 Mg)
Recruiting
- HIV I Infection
- +2 more
- Doravirine 100 Mg
-
Los Angeles, California
- +1 more
Nov 1, 2022
Metabolic Effects, Weight Gain, HIV Trial run by the National Institute of Allergy and Infectious Diseases (NIAID) (Tenofovir
Not yet recruiting
- Metabolic Effects
- +3 more
- Tenofovir alafenamide
- Dolutegravir
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Gut Microbiota, PGx and INSTIs Response
Recruiting
- HIV Infections
-
Brussels, BelgiumCliniques universitaires Saint-Luc
Jan 16, 2023